SonlicromanolSonlicromanol (KH176) is a clinical-stage oral drug compound developed by Khondrion as a potential treatment for primary and secondary mitochondrial diseases, such as Leigh's Disease, MELAS and LHON. Read from the Chembox of the Wikipedia article Sonlicromanol, revision 1370302943.

Property

Value

Formula

C19H28N2O3, 332.44 g/mol

Melting point

226.2 °C

Boiling point

570.8 °C

Density

1.2 g/cm³

Flash point

299 °C

log P, measured

2.39

pKa

8.9

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.